S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Henry Ford Would NEVER Have Seen This Coming (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Henry Ford Would NEVER Have Seen This Coming (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Henry Ford Would NEVER Have Seen This Coming (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Trading Experts Call It “The Perfect Tesla Trade” (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Henry Ford Would NEVER Have Seen This Coming (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts

Sanara MedTech Stock Price, News & Analysis (NASDAQ:SMTI)

$32.93
-0.27 (-0.81%)
(As of 12/6/2023 ET)
Compare
Today's Range
$31.99
$33.62
50-Day Range
$26.33
$34.10
52-Week Range
$26.06
$50.18
Volume
15,330 shs
Average Volume
16,089 shs
Market Capitalization
$281.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$49.00

Sanara MedTech MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
48.8% Upside
$49.00 Price Target
Short Interest
Healthy
3.43% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.19mentions of Sanara MedTech in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.70) to $0.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Medical Sector

245th out of 957 stocks

Surgical Appliances & Supplies Industry

9th out of 18 stocks


SMTI stock logo

About Sanara MedTech Stock (NASDAQ:SMTI)

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It also offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

SMTI Stock Price History

SMTI Stock News Headlines

New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Sanara MedTech Inc. Announces Third Quarter 2023 Results
Sanara MedTech Inc SMTI
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Sanara MedTech to Participate in Two Upcoming Conferences
SMTI - Sanara MedTech Inc.
Sanara MedTech: Q1 Earnings Insights
See More Headlines
Receive SMTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sanara MedTech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/18/2024

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SMTI
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$49.00
High Stock Price Target
$49.00
Low Stock Price Target
$49.00
Potential Upside/Downside
+47.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-7,940,000.00
Pretax Margin
-13.32%

Debt

Sales & Book Value

Annual Sales
$45.84 million
Book Value
$5.02 per share

Miscellaneous

Free Float
3,825,000
Market Cap
$283.10 million
Optionable
Not Optionable
Beta
1.75
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Ronald T. Nixon (Age 67)
    Executive Chairman
  • Mr. Zachary B. FlemingMr. Zachary B. Fleming (Age 48)
    Chief Executive Officer
    Comp: $593.64k
  • Mr. Michael D. McNeil (Age 58)
    CFO & Corporate Secretary
    Comp: $438.68k
  • Dr. Christopher A. Morrison FACHM (Age 53)
    FAPWCA, FCCWS, M.D., President of Telehealth Services
    Comp: $156k
  • Mr. Callon Nichols
    Vice President of Corporate Operations
  • Mr. Bill Fitzgerald
    Chief Compliance Officer
  • Ms. Tricia Matteson
    Vice President of Marketing
  • Dr. Rebecca Erin Mcmahon (Age 38)
    President of Research & Development
  • Mr. Ryan Phillips
    President of Biologics
  • Mr. Seth Yon
    President of Commercial














SMTI Stock Analysis - Frequently Asked Questions

Should I buy or sell Sanara MedTech stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sanara MedTech in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SMTI shares.
View SMTI analyst ratings
or view top-rated stocks.

What is Sanara MedTech's stock price target for 2024?

1 Wall Street analysts have issued twelve-month price objectives for Sanara MedTech's stock. Their SMTI share price targets range from $49.00 to $49.00. On average, they predict the company's stock price to reach $49.00 in the next year. This suggests a possible upside of 48.8% from the stock's current price.
View analysts price targets for SMTI
or view top-rated stocks among Wall Street analysts.

How have SMTI shares performed in 2023?

Sanara MedTech's stock was trading at $45.50 at the beginning of the year. Since then, SMTI shares have decreased by 27.6% and is now trading at $32.93.
View the best growth stocks for 2023 here
.

When is Sanara MedTech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 18th 2024.
View our SMTI earnings forecast
.

How were Sanara MedTech's earnings last quarter?

Sanara MedTech Inc. (NASDAQ:SMTI) announced its earnings results on Monday, November, 13th. The company reported ($0.13) earnings per share (EPS) for the quarter. The business earned $16.03 million during the quarter. Sanara MedTech had a negative net margin of 13.05% and a negative trailing twelve-month return on equity of 20.51%.

What other stocks do shareholders of Sanara MedTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sanara MedTech investors own include Lakeland Industries (LAKE), Ovintiv (OVV), SIG (SHI), Zynerba Pharmaceuticals (ZYNE), AbbVie (ABBV), American Airlines Group (AAL), Abbott Laboratories (ABT), Aurora Cannabis (ACB), AC Immune (ACIU) and Applied Genetic Technologies (AGTC).

Who are Sanara MedTech's major shareholders?

Sanara MedTech's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Northern Trust Corp (0.36%), Quadrature Capital Ltd (0.18%), Janney Montgomery Scott LLC (0.13%), Lazard Asset Management LLC (0.03%), New York State Common Retirement Fund (0.03%) and UBS Group AG (0.03%). Insiders that own company stock include Shawn M Bowman and Zachary B Fleming.
View institutional ownership trends
.

How do I buy shares of Sanara MedTech?

Shares of SMTI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SMTI) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -